CPS-168 - Strategies for professional pharmaceutical impact on Alzheimer's disease

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: CPS-168
• By: DODERA MARTINEZ, Gustavo (Universidad John F . Kennedy, Argentina)
• Co-author(s): Prof Gustavo Dodera Martinez (Universidad John F . Kennedy, CIUDAD DE BUENOS AIRES , Argentina)
  Prof Susana Migliaro (Universidad John F . Kennedy, CIUDAD DE BUENOS AIRES , Argentina)
  Prof Laura Raccagni (Universidad John F . Kennedy, CIUDAD DE BUENOS AIRES , Argentina)
  Pharm Sara Ramayo Riva (Universidad John F . Kennedy, CIUDAD DE BUENOS AIRES , Argentina)
  
• Abstract:

  Introduction: Alzheimer's disease involves a decline in cognitive abilities and functional capacity, along with the appearance of behavioral and psychological symptoms. Dementia, cognitive disorders, and Alzheimer's disease are multifactorial disorders that require a multidisciplinary approach. Alzheimer's is the fifth leading cause of death in..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login